<?xml version="1.0" encoding="UTF-8"?>
<p id="par0215">In addition to direct potentiation of the interferon response, other cell signaling pathways have been identified as potential anti-CoV treatment targets. Cyclophilins interact with SARS-CoV nsp1 to modulate the calcineurin pathway, which is important in the T cell-mediated adaptive immune response 
 <xref rid="bib0710" ref-type="bibr">[142]</xref>. The calcineurin inhibitor cyclosporine (
 <bold>90</bold>, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) inhibits a broad range of CoVs 
 <italic>in vitro</italic>
 <xref rid="bib0710" ref-type="bibr">142</xref>, 
 <xref rid="bib0715" ref-type="bibr">143</xref>, 
 <xref rid="bib0720" ref-type="bibr">144</xref>. However, its immunosuppressive effects and high EC
 <sub>50</sub>/Cmax ratio at standard therapeutic dosages limit its clinical application.
</p>
